← Leaderboards
James Laurence Labelle
Dana-Farber Cancer Inst
$842,293
Attributed
$842,293
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $170.1K · FY2011–15$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$842,293 · 1
By mechanism
K08$842,293 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Anthony G Letai$22,380,537
- Gregory Howard Bird$3,139,726
- Ursula Anne Matulonis$3,602,637
- Andrew A Lane$4,246,865
- Geoffrey I Shapiro$18,639,470
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAnimal TestingApoptosisAffinityAutophagocytosisBax GeneB-Cell DevelopmentB-Cell LymphomasApoptoticAlpha HelixBcl2l11 GeneBcl-2 ProteinBim Bcl-2-Binding ProteinBiochemicalBiochemistryBiologicalBiologyB-LymphocytesB Lymphoid MalignancyCancer BiologyCancer CellCell DeathCell LineCessation Of Life
Grant awards (6)
Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma$168,048
K08 · FY2015 · CA · contact PI
Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma$168,048
K08 · FY2014 · CA · contact PI
Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma$168,048
K08 · FY2013 · CA · contact PI
Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma$168,048
K08 · FY2012 · CA · contact PI
Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma$1
K08 · FY2012 · CA · contact PI
Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma$170,100
K08 · FY2011 · CA · contact PI